| The ability of skeletal muscle and tendon to adapt to use and disuse has important consequences for determining the health, mobility and athletic performance of an individual. Muscle generates the forces for locomotion, and tendons link muscle to bone and can protect muscle fibers from contraction-induced injuries. Myostatin (GDF-8) is a member of the TGF-beta superfamily of cytokines. Inhibition of myostatin leads to a profound increase in muscle mass, and consequently there is much interest in the potential of myostatin inhibitors to treat injuries and diseases that lead to muscle atrophy. Using whole muscle and tendon mechanics experiments in the myostatin-deficient mouse model, along with cellular and molecular studies, we determined the impact of myostatin deficiency on the structure and function of skeletal muscle and tendon tissue.;The deficiency of myostatin leads to muscle fiber hypertrophy and hyperplasia. Myostatin-deficient EDL muscles have a decrease in protein degradation due to a decrease in atrogin-1 expression. Myostatin deficiency decreased the type I collagen content of EDL muscles. The deficiency of myostatin increased the maximum isometric force of both EDL and soleus muscles, but decreased the specific force of EDL muscles. Furthermore, EDL muscles of myostatin-deficient mice are more susceptible to contraction-induced injury. Therefore, we determined if myostatin regulates the structure and function of tendons.;Transcripts for myostatin and the myostatin receptors, ACVR2B and ACVRB, are present in tendons. Surprisingly, the tendons of myostatin-deficient mice are smaller, have a decrease in fibroblast density and type I collagen. Myostatin-deficient tendons also have a decrease in the expression of two genes that promote tendon fibroblast proliferation, scleraxis and tenomodulin. Treatment of tendon fibroblasts with myostatin activates the p38MAPK and Smad2/3 signaling cascades, increases cell proliferation and the expression of type I collagen, scleraxis and tenomodulin. Tendons from myostatin-deficient mice have a greater peak stress, lower peak strain and an increase in stiffness. We conclude that myostatin has a profound impact on the structure and function of skeletal muscle and tendon tissue. The partial inhibition of myostatin is likely to be beneficial in the treatment of many types of muscle injuries and diseases. |
